Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ornithine-Transcarbamylase Deficiency market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ornithine-Transcarbamylase Deficiencymarket, defines the market attractiveness level of Ornithine-Transcarbamylase Deficiency market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ornithine-Transcarbamylase Deficiency industry, describes the types of Ornithine-Transcarbamylase Deficiency market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ornithine-Transcarbamylase Deficiency market and the development prospects and opportunities of Ornithine-Transcarbamylase Deficiency industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ornithine-Transcarbamylase Deficiency market in Chapter 13.
By Player:
PhaseRx Inc
Lucane Pharma SA
Ultragenyx Pharmaceutical Inc
Selecta Biosciences Inc
Promethera Biosciences SA
Translate Bio Inc
Unicyte AG
By Type:
DTX-301
SEL-313
SHP-641
PRX-OTC
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ornithine-Transcarbamylase Deficiency Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ornithine-Transcarbamylase Deficiency Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ornithine-Transcarbamylase Deficiency Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ornithine-Transcarbamylase Deficiency Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ornithine-Transcarbamylase Deficiency Market Analysis and Outlook to 2022
-
7.1 Global Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.2 United States Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.3 Europe Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.4 China Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.5 Japan Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.6 India Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
-
7.7 South Korea Ornithine-Transcarbamylase Deficiency Consumption (2017-2022)
8 Region and Country-wise Ornithine-Transcarbamylase Deficiency Market Analysis and Outlook to 2028
-
8.1 Global Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.2 United States Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.3 Europe Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.4 China Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.5 Japan Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.6 India Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
-
8.7 South Korea Ornithine-Transcarbamylase Deficiency Consumption Forecast (2022-2028)
9 Global Ornithine-Transcarbamylase Deficiency Market Outlook by Types and Applications to 2022
-
9.1 Global Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global DTX-301 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global SEL-313 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global SHP-641 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global PRX-OTC Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Ornithine-Transcarbamylase Deficiency Market Outlook by Types and Applications to 2028
-
10.1 Global Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global DTX-301 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global SEL-313 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global SHP-641 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global PRX-OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Ornithine-Transcarbamylase Deficiency Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ornithine-Transcarbamylase Deficiency Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ornithine-Transcarbamylase Deficiency Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ornithine-Transcarbamylase Deficiency Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ornithine-Transcarbamylase Deficiency Market Competitive Analysis
-
14.1 PhaseRx Inc
-
14.1.1 PhaseRx Inc Company Details
-
14.1.2 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
14.2 Lucane Pharma SA
-
14.2.1 Lucane Pharma SA Company Details
-
14.2.2 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Product and Service
-
14.3 Ultragenyx Pharmaceutical Inc
-
14.3.1 Ultragenyx Pharmaceutical Inc Company Details
-
14.3.2 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
14.4 Selecta Biosciences Inc
-
14.4.1 Selecta Biosciences Inc Company Details
-
14.4.2 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
14.5 Promethera Biosciences SA
-
14.5.1 Promethera Biosciences SA Company Details
-
14.5.2 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Product and Service
-
14.6 Translate Bio Inc
-
14.6.1 Translate Bio Inc Company Details
-
14.6.2 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
14.7 Unicyte AG
-
14.7.1 Unicyte AG Company Details
-
14.7.2 Unicyte AG Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Unicyte AG Ornithine-Transcarbamylase Deficiency Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ornithine-Transcarbamylase Deficiency
-
Figure Ornithine-Transcarbamylase Deficiency Picture
-
Table Global Ornithine-Transcarbamylase Deficiency Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ornithine-Transcarbamylase Deficiency Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ornithine-Transcarbamylase Deficiency Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ornithine-Transcarbamylase Deficiency Consumption by Country (2017-2022)
-
Figure United States Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Table Europe Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Figure China Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Figure Japan Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Figure India Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ornithine-Transcarbamylase Deficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Ornithine-Transcarbamylase Deficiency Consumption Forecast by Country (2022-2028)
-
Figure United States Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ornithine-Transcarbamylase Deficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DTX-301 Consumption and Growth Rate (2017-2022)
-
Figure Global SEL-313 Consumption and Growth Rate (2017-2022)
-
Figure Global SHP-641 Consumption and Growth Rate (2017-2022)
-
Figure Global PRX-OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global DTX-301 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SEL-313 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SHP-641 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PRX-OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ornithine-Transcarbamylase Deficiency Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ornithine-Transcarbamylase Deficiency Export by Region (Top 5 Countries) (2017-2028)
-
Table PhaseRx Inc (Foundation Year, Company Profile and etc.)
-
Table PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table PhaseRx Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Lucane Pharma SA (Foundation Year, Company Profile and etc.)
-
Table Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Ultragenyx Pharmaceutical Inc (Foundation Year, Company Profile and etc.)
-
Table Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Selecta Biosciences Inc (Foundation Year, Company Profile and etc.)
-
Table Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Promethera Biosciences SA (Foundation Year, Company Profile and etc.)
-
Table Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Translate Bio Inc (Foundation Year, Company Profile and etc.)
-
Table Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Translate Bio Inc Ornithine-Transcarbamylase Deficiency Product and Service
-
Table Unicyte AG (Foundation Year, Company Profile and etc.)
-
Table Unicyte AG Ornithine-Transcarbamylase Deficiency Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unicyte AG Ornithine-Transcarbamylase Deficiency Product and Service
-
